Platz KP - Search Results

1

The extracellular matrix: an early target of preservation/reperfusion injury and acute rejection after small bowel transplantation.

Mueller AR, Platz KP, Heckert C, Häusler M, Guckelberger O, Schuppan D, Lobeck H, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplantation. 1998 Mar 27;65(6):770-6. doi: 10.1097/00007890-199803270-00002. Transplantation. 1998. PMID: 9539087

2

Monitoring of immunosuppression after clinical small bowel transplantation.

Pascher A, Sauer IM, Schulz RJ, Platz K, Theruvath T, Dignass A, Radke C, Neuhaus P, Mueller AR. Pascher A, et al. Transplant Proc. 2002 May;34(3):931-3. doi: 10.1016/s0041-1345(02)02676-3. Transplant Proc. 2002. PMID: 12034245 No abstract available.

3

Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.

Mueller AR, Platz KP, Bechstein WO, Schattenfroh N, Stoltenburg-Didinger G, Blumhardt G, Christe W, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplantation. 1994 Jul 27;58(2):155-70. Transplantation. 1994. PMID: 7518974 Clinical Trial.

4

Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506.

Platz KP, Mueller AR, Blumhardt G, Bachmann S, Bechstein WO, Kahl A, Neuhaus P. Platz KP, et al. Transplantation. 1994 Jul 27;58(2):170-8. Transplantation. 1994. PMID: 7518975 Clinical Trial.

5

Increased rejection after liver transplantation in FK 506-treated patients is associated with viral hepatitis C disease.

Mueller AR, Platz KP, Bechstein WO, Blumhardt G, Lobeck H, Hop U, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Transplant Proc. 1994 Dec;26(6):3637-9. Transplant Proc. 1994. PMID: 7527984 No abstract available.

6

Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.

Neuhaus P, Blumhardt G, Bechstein WO, Platz KP, Jonas S, Mueller AR, Langrehr JM, Lohmann R, Schattenfroh N, Knoop M, et al. Neuhaus P, et al. Among authors: platz kp. Transplantation. 1995 Jan 15;59(1):31-40. doi: 10.1097/00007890-199501150-00007. Transplantation. 1995. PMID: 7530868 Clinical Trial.

7

OKT3 vs FK 506 rescue management of acute steroid-resistant and chronic rejection.

Platz KP, Mueller AR, Zytowski M, Bechstein WO, Blumhardt G, Lobeck H, Neuhaus P. Platz KP, et al. Transplant Proc. 1995 Feb;27(1):1111-3. Transplant Proc. 1995. PMID: 7533357 Clinical Trial. No abstract available.

8

Toxicity versus rejection--or why conversions between cyclosporine A and FK506 were performed after liver transplantation.

Platz KP, Mueller AR, Jonas S, Blumhardt G, Bechstein WO, Lobeck H, Neuhaus HL. Platz KP, et al. Clin Transplant. 1995 Jun;9(3 Pt 1):146-54. Clin Transplant. 1995. PMID: 7549052 Clinical Trial.

9

The optimal immunosuppressant after liver transplantation according to diagnosis: cyclosporine A or FK506?

Mueller AR, Platz KP, Blumhardt G, Bechstein WO, Steinmüller T, Christe W, Hopf U, Lobeck H, Neuhaus P. Mueller AR, et al. Among authors: platz kp. Clin Transplant. 1995 Jun;9(3 Pt 1):176-84. Clin Transplant. 1995. PMID: 7549057 Clinical Trial.

10

The effects of administration of nitric oxide inhibitors during small bowel preservation and reperfusion.

Mueller AR, Platz KP, Langrehr JM, Hoffman RA, Nussler AK, Nalesnik M, Billiar TR, Schraut WH. Mueller AR, et al. Among authors: platz kp. Transplantation. 1994 Dec 27;58(12):1309-16. Transplantation. 1994. PMID: 7809922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters